Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections Using Home-Collected Specimens
What happened
The Food and Drug Administration (FDA) is classifying devices for detecting non-viral sexually transmitted infections (STIs) from home-collected specimens into Class II (special controls). This action, signed by Donald Trump, establishes special controls to ensure the device's safety and effectiveness. The special controls will become part of the codified language for this device classification.
Why it matters
This classification aims to provide reasonable assurance that these home-testing devices are safe and effective. It is also intended to improve patient access to innovative medical devices by reducing regulatory burdens.
Who it affects
- ›Patients needing STI testing
- ›Medical device manufacturers
- ›Healthcare providers
- ›Individuals with sexually transmitted infections
The receipts are official. The summary is ours.
Read on Federal Register ↗Summaries are generated from the official text and may simplify or omit nuance. The official document is the source of truth.